Evidence on the construct validity of the Health Utilities Index Mark 2 and Mark 3 in patients with chronic kidney disease
β Scribed by Sara N. Davison; Gian S. Jhangri; David H. Feeny
- Publisher
- Springer Netherlands
- Year
- 2008
- Tongue
- English
- Weight
- 260 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0962-9343
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Our objective was to adapt and validate the Health Utilities Index Mark 2 (HUI 2) and HUI 3 health status classification systems self-report questionnaire in a population of children with cancer, a group of 42 children already included in a multi-centre database designed by the Group on Brain Tumors
## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the healthβrelated quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fiftyβeight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC